Learn about immunotherapy's role in treating Lynch syndrome-related cancers in this 13-minute medical presentation from Dana-Farber Cancer Institute oncologist Dr. Leah Biller, who explains the mechanisms of immunotherapy and its specific applications for patients with Lynch syndrome cancers.
Overview
Syllabus
New Approaches to Management: Immunotherapy to Treat Lynch Syndrome Cancers
Taught by
Dana-Farber Cancer Institute
Related Courses
-
New Approaches to Managing Lynch Syndrome - Chemoprevention and Immunoprevention
-
Exercise as a Cancer Prevention Agent - Implications for Lynch Syndrome
-
Immunotherapy and Immune Prevention in Lynch Syndrome - Session 3
-
Lynch Syndrome - Gene-Specific Risks and Associated Cancer Types
-
Early Innovative Combination Immunotherapy Trials for Colorectal Cancer Treatment
-
Immunotherapy for Esophageal and Gastric Cancer - Understanding the Science
